TD Cowen Downgrades Elevation Oncology (ELEV) to Hold Jun 9, 2025 04:03PM
Elevation Oncology to Participate in Upcoming Investor Conferences Feb 25, 2025 07:30AM
TD Cowen Reiterates Buy Rating on Elevation Oncology (ELEV) Aug 6, 2024 01:51PM
TD Cowen Reiterates Buy Rating on Elevation Oncology (ELEV) Jun 28, 2024 10:38AM
Elevation Oncology to Participate in Upcoming Investor Conferences Feb 28, 2024 07:30AM


Jun 9, 2023 05:36AM Elevation Oncology (ELEV) Prices $50M Share Offering at $2.25/sh
Jun 8, 2023 10:41PM Elevation Oncology Announces Pricing of $50 Million Public Offering
Jun 8, 2023 04:02PM Elevation Oncology (ELEV) Announces Launch of Proposed Public Offering of Common Stock, Warrants
Jun 8, 2023 04:01PM Elevation Oncology Announces Launch of Proposed Public Offering
Mar 1, 2023 07:00AM Elevation Oncology to Participate at Upcoming Investor Conferences
Jun 1, 2022 07:30AM Elevation Oncology to Participate at Cowen's 3rd Annual Oncology Innovation Summit
Mar 1, 2022 07:00AM Elevation Oncology to Participate at Upcoming Virtual Investor Conferences
Jul 20, 2021 06:18AM UPDATE: Cowen Starts Elevation Oncology (ELEV) at Outperform
Jun 25, 2021 01:11PM Elevation Oncology (ELEV) IPO Opens 12.5% Lower
Jun 25, 2021 05:10AM Elevation Oncology (ELEV) Prices 6.25M Share IPO at $16/sh
Jun 24, 2021 08:44PM Elevation Oncology Announces Pricing of Initial Public Offering
Jun 23, 2021 03:42PM Elevation Oncology (ELEV) Files 6.25M Share IPO at $15-$17/sh